Tenboron
Tenboron provides boron carriers for Boron Neutron Capture Therapy in cancer treatment.
Funding rounds
6/2021
Valuation in latest round
€19.1 million
Springvest's ownership stake
1.9% (31 December 2025)
Sector
Life sciences
Explore other companies
1/1